It should also be noted that the relationship of the IL1B rs16944*TT genotype with the nonachieving of the ACR Pedi 70 response to etanercept in JIA was previously established, which is important to consider when selecting the second-line therapy for these patients [33]. Here, IL1B is linked to juvenile idiopathic arthritis.